Table 4.
Family | miRNA members | Adenocarcinoma
|
Squamous Cell Carcinomas
|
||
---|---|---|---|---|---|
Function | Former | Current | Former | Current | |
|
|
||||
P-value* | P-value* | P-value* | P-value* | ||
Let-7 family | hsa-miR-let-7a | P <0.001 | P =0.426 | P =0.366 | P =0.988 |
Tumor suppressor | hsa-miR-let-7b | ||||
hsa-miR-let-7c | |||||
hsa-miR-let-7d | |||||
hsa-miR-let-7e | |||||
hsa-miR-let-7f | |||||
hsa-miR-let-7g | |||||
hsa-miR-let-7i | |||||
hsa-miR-98 | |||||
hsa-miR-202 | |||||
miR-146 family | hsa-miR-146a | P =0.002 | P =0.092 | P =0.753 | P =0.222 |
Tumor growth and invasion | hsa-miR-146b | ||||
miR-26 family | hsa-miR-26a | P =0.010 | P =0.623 | P =0.588 | P =0.664 |
Apoptosis | hsa-miR-26b | ||||
miR-17 family | hsa-miR-20a | P =0.031 | P =0.943 | P =0.766 | P =0.283 |
Tumor progression | hsa-miR-20b | ||||
hsa-miR-106a | |||||
hsa-miR-106b | |||||
hsa-miR-17-5p | |||||
hsa-miR-93 | |||||
miR-29 family | hsa-miR-29a | P =0.064 | P =0.373 | P =0.886 | P =0.137 |
DNA methylation | hsa-miR-29b | ||||
hsa-miR-29c | |||||
miR-18 family | hsa-miR-18a | P =0.705 | P =0.220 | P =0.156 | P =0.392 |
Tumor progression | hsa-miR-18b | ||||
miR-34 family | hsa-miR-34a | P =0.142 | P =0.649 | P =0.275 | P =0.568 |
Tumor suppressor | hsa-miR-34c | ||||
miR-19 family | hsa-miR-19a | P =0.072 | P =0.991 | P =0.608 | P =0.103 |
Tumor progression | hsa-miR-19b | ||||
miR-15/16 family | hsa-miR-503 | P =0.286 | P =0.073 | P =0.307 | P =0.763 |
Apoptosis | hsa-miR-15a | ||||
hsa-miR-16 | |||||
hsa-miR-195 | |||||
hsa-miR-424 |
NOTE: Only results of miR families that had at least one miR that were significant at p-value <0.05 from individual-based miR analyses (Table 2); Bolded p-values indicated results that remained significant after Bonferroni correction for multiple comparisons
Models adjusted for age, sex, BMI, non-quercetin-rich fruits and vegetables, red/processed meat, alcohol, and cigarette packyears.
Refer to Supplemental Table S5 for more detailed functions
P-value based on Functional Class Score as described in the Methods section